WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004005331) PEPTIDES DERIVED FROM PEP133 (G1P3, 6-16)
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/005331    International Application No.:    PCT/EP2003/006535
Publication Date: 15.01.2004 International Filing Date: 20.06.2003
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: GENEPROT, INC. [CH/CH]; 2, rue Pré de la Fontaine, Case Postale 125, CH-1217 Meyrin 2 (CH) (For All Designated States Except US).
ARGOUD-PUY, Guilaine [FR/CH]; (CH) (For US Only).
BOUGUELERET, Lydie [FR/CH]; (CH) (For US Only)
Inventors: ARGOUD-PUY, Guilaine; (CH).
BOUGUELERET, Lydie; (CH)
Agent: VOSSIUS & PARTNER; Siebertstrasse 4, 81675 Munich (DE)
Priority Data:
60/393,695 02.07.2002 US
Title (EN) PEPTIDES DERIVED FROM PEP133 (G1P3, 6-16)
(FR) PEPTIDES SECRETES
Abstract: front page image
(EN)The invention provides novel human secreted peptides having an amino acid sequence of SEQ ID NOS 3, 5 and 7. The invention also provides the amidated forms of these polypeptides as SEQ ID NOS 4, 6 and 8, and compositions including polypeptides, polynucleotides, and antibodies specific for these peptides. Also provided are methods for making such compositions, and methods of using the compositions of the invention for diagnosis, prognosis, and treatment of diseases.
(FR)L'invention concerne de nouveaux peptides humains sécrétés comprenant une séquence d'acides aminés des SEQ ID NOS. 3, 5 et 7. L'invention concerne également des formes amidées desdits polypeptides en tant que SEQ ID NOS 4, 6 et 8, et des compositions comprenant des polypeptides, des polynucléotides et des anticorps spécifiques de ces peptides. L'invention concerne en outre des méthodes de production des compositions de l'invention, et des méthodes utilisant ces compositions pour diagnostiquer, pronostiquer ou traiter des troubles cardiovasculaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)